JP2019151636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019151636A5 JP2019151636A5 JP2019071529A JP2019071529A JP2019151636A5 JP 2019151636 A5 JP2019151636 A5 JP 2019151636A5 JP 2019071529 A JP2019071529 A JP 2019071529A JP 2019071529 A JP2019071529 A JP 2019071529A JP 2019151636 A5 JP2019151636 A5 JP 2019151636A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue
- composition
- dengue virus
- serotype
- cyd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305907.3 | 2012-07-24 | ||
| EP12305907 | 2012-07-24 | ||
| EP12305912 | 2012-07-25 | ||
| EP12305912.3 | 2012-07-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523548A Division JP2015524421A (ja) | 2012-07-24 | 2013-07-24 | ワクチン組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019151636A JP2019151636A (ja) | 2019-09-12 |
| JP2019151636A5 true JP2019151636A5 (enExample) | 2019-10-24 |
| JP6830118B2 JP6830118B2 (ja) | 2021-02-17 |
Family
ID=48875047
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523548A Ceased JP2015524421A (ja) | 2012-07-24 | 2013-07-24 | ワクチン組成物 |
| JP2019071529A Active JP6830118B2 (ja) | 2012-07-24 | 2019-04-03 | ワクチン組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523548A Ceased JP2015524421A (ja) | 2012-07-24 | 2013-07-24 | ワクチン組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20150196631A1 (enExample) |
| EP (2) | EP3932422A1 (enExample) |
| JP (2) | JP2015524421A (enExample) |
| KR (2) | KR20200067938A (enExample) |
| CN (1) | CN104812407B (enExample) |
| AU (1) | AU2013295014B2 (enExample) |
| MX (2) | MX381497B (enExample) |
| MY (2) | MY197723A (enExample) |
| PH (1) | PH12014502840A1 (enExample) |
| SG (2) | SG10201912291YA (enExample) |
| WO (1) | WO2014016360A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201500439RA (en) * | 2012-07-24 | 2015-02-27 | Sanofi Pasteur | Vaccine compositions for prevention against dengue virus infection |
| CA3166063A1 (en) | 2013-03-15 | 2014-09-25 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
| TWI852899B (zh) * | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| SG11201706342PA (en) * | 2015-02-09 | 2017-09-28 | Academia Sinica | An epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses |
| EP3316905A1 (en) * | 2015-07-03 | 2018-05-09 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| EP3147294B1 (en) * | 2015-09-24 | 2020-04-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Distinguishing dengue virus infections from other flaviviral infections using a recombinant mutant envelope protein |
| US10655110B2 (en) * | 2015-11-27 | 2020-05-19 | Km Biologics Co., Ltd. | Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes |
| MY192806A (en) * | 2016-04-13 | 2022-09-09 | Takeda Vaccines Inc | Compositions and methods of vaccination against dengue virus in children and young adults |
| US11531029B2 (en) | 2017-05-08 | 2022-12-20 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods and compositions for the detection of flavivirus infections |
| SG11202002933TA (en) | 2017-10-05 | 2020-04-29 | Sanofi Pasteur | Compositions for booster vaccination against dengu |
| WO2019113285A2 (en) | 2017-12-06 | 2019-06-13 | Emory University | Zika vaccines and methods of use |
| EP3549603A1 (en) | 2018-04-06 | 2019-10-09 | Sanofi Pasteur | Live-attenuated yellow fever virus strain adapted to grow on vero cells and vaccine composition comprising the same |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| IL298307A (en) | 2018-09-05 | 2023-01-01 | Takeda Vaccines Inc | Dengue fever vaccine unit dose and its administration |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| CN112079934B (zh) * | 2019-12-17 | 2021-01-29 | 合源生物科技(天津)有限公司 | 一种靶向cd19的嵌合抗原受体及其用途 |
| CN116334070B (zh) * | 2023-02-15 | 2026-02-06 | 天津大学 | 融合蛋白的应用和细胞融合的方法 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US109A (en) | 1836-12-15 | Erawijtg | ||
| US5422A (en) | 1848-02-01 | Spark-arrester | ||
| JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| FR2649012B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Emulsions multiphasiques injectables |
| FR2649013B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6254873B1 (en) | 1995-04-17 | 2001-07-03 | The United States Of America As Represented By The Secretary Of The Army | Inactivated dengue virus vaccine |
| AU6093296A (en) | 1995-06-07 | 1996-12-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
| ES2345614T3 (es) | 1997-02-28 | 2010-09-28 | Sanofi Pasteur Biologics Co. | Vacunas quimericas de flavivirus. |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| CA2302554C (en) | 1997-09-05 | 2007-04-10 | Smithkline Beecham Biologicals S.A. | Oil in water emulsions containing saponins |
| EP1165130A2 (en) | 1999-03-26 | 2002-01-02 | Walter Reed Army Institute of Research | Attenuated dengue-3 virus vaccine |
| CA2365411A1 (en) | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-2 virus vaccine |
| JP2002540169A (ja) | 1999-03-26 | 2002-11-26 | ウォルター リード アーミー インスティテュート オブ リサーチ | 弱毒化デング熱１型ウイルスワクチン |
| JP2002540171A (ja) | 1999-03-26 | 2002-11-26 | ウォルター リード アーミー インスティテュート オブ リサーチ | 弱毒化デング熱４型ウイルスワクチン |
| US7094411B2 (en) | 2000-02-16 | 2006-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Avirulent, immunogenic flavivirus chimeras |
| ATE412738T1 (de) | 2000-05-30 | 2008-11-15 | Univ Mahidol | Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen |
| AT410634B (de) | 2001-02-21 | 2003-06-25 | Franz X Dr Heinz | Attenuierte lebendimpfstoffe |
| EP2290108B1 (en) | 2001-05-22 | 2014-07-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| JP2005518332A (ja) | 2001-05-23 | 2005-06-23 | デンドレオン コーポレイション | 細胞表面のプロテアーゼにより活性化される結合体およびその治療的使用 |
| JP2005501532A (ja) | 2001-06-01 | 2005-01-20 | アカンビス インコーポレーティッド | キメラフラビウイルスベクター |
| KR101074175B1 (ko) * | 2002-01-15 | 2011-10-14 | 사노피 파스테르 바이오로직스 씨오 | 플라비바이러스 백신 |
| WO2003101397A2 (en) | 2002-05-31 | 2003-12-11 | Acambis, Inc. | Tetravalent dengue vaccines |
| JP5197362B2 (ja) | 2005-06-17 | 2013-05-15 | サノフィ・パスツール | デング熱セロタイプ１弱毒株 |
| BRPI0613287A2 (pt) | 2005-06-17 | 2010-12-28 | Sanofi Pasteur | cepa do vìrus da dengue-2 vivo atenuada, composição imunogênica, composição de vacina, ácido nucléico isolado, poliproteìna isolada codificadas pela seq id n .1 ou fragmentos desta e fragmento da poliproteìna |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
| WO2007021672A2 (en) | 2005-08-10 | 2007-02-22 | Acambis Inc. | Vaccination against dengue virus infection |
| BRPI0618850A2 (pt) * | 2005-11-21 | 2011-09-13 | Sanofi Pasteur Ltd | formulações de estabilização para vìrus recombinantes |
| FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
| US7968102B2 (en) * | 2006-01-13 | 2011-06-28 | Sanofi Pasteur S.A. | Dengue chimeric viruses |
| FR2903605A1 (fr) * | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| GB201007531D0 (en) | 2010-05-05 | 2010-06-23 | Imp Innovations Ltd | Composition |
-
2013
- 2013-07-24 EP EP21173406.6A patent/EP3932422A1/en active Pending
- 2013-07-24 MY MYPI2018700631A patent/MY197723A/en unknown
- 2013-07-24 KR KR1020207016038A patent/KR20200067938A/ko not_active Ceased
- 2013-07-24 WO PCT/EP2013/065667 patent/WO2014016360A1/en not_active Ceased
- 2013-07-24 MX MX2015000442A patent/MX381497B/es unknown
- 2013-07-24 SG SG10201912291YA patent/SG10201912291YA/en unknown
- 2013-07-24 AU AU2013295014A patent/AU2013295014B2/en active Active
- 2013-07-24 CN CN201380049627.XA patent/CN104812407B/zh active Active
- 2013-07-24 MY MYPI2014003501A patent/MY168959A/en unknown
- 2013-07-24 JP JP2015523548A patent/JP2015524421A/ja not_active Ceased
- 2013-07-24 KR KR20157003821A patent/KR20150036592A/ko not_active Ceased
- 2013-07-24 US US14/416,496 patent/US20150196631A1/en not_active Abandoned
- 2013-07-24 EP EP13741748.1A patent/EP2877208B1/en active Active
- 2013-07-24 SG SG11201500412TA patent/SG11201500412TA/en unknown
-
2014
- 2014-12-19 PH PH12014502840A patent/PH12014502840A1/en unknown
-
2015
- 2015-01-09 MX MX2021004211A patent/MX2021004211A/es unknown
-
2018
- 2018-09-06 US US16/123,319 patent/US20190201517A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019071529A patent/JP6830118B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019151636A5 (enExample) | ||
| Amann et al. | A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein | |
| Christensen et al. | Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory | |
| JP2015524421A5 (enExample) | ||
| JP2017526689A5 (enExample) | ||
| JP2019526580A5 (enExample) | ||
| Chernokhaeva et al. | Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin | |
| Baehner et al. | Vaccines against norovirus: state of the art trials in children and adults | |
| CA2755257A1 (en) | Replication-defective flavivirus vaccine vectors against respiratory syncytial virus | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| Jiang et al. | Polio endgame: Lessons for the global rotavirus vaccination program | |
| JP2016504315A5 (enExample) | ||
| Moreno et al. | Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge | |
| CN105473603A (zh) | 用于登革病毒疫苗的方法与组合物 | |
| Babaeimarzangou et al. | Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families | |
| US20230210980A1 (en) | Chimeric adenoviral vectors | |
| US10590174B2 (en) | Genomic sequences encoding for an attenuated mutant Zika virus | |
| Schäfer et al. | Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever | |
| CN102847147B (zh) | 番鸭细小病毒病和番鸭呼肠孤病毒病二联活疫苗 | |
| Lim et al. | Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials | |
| JP6259831B2 (ja) | Ｃ型肝炎ウイルスに対するキメラワクチン抗原 | |
| JP2020536107A5 (enExample) | ||
| Morrison et al. | Viral vaccines: fighting viruses with vaccines | |
| Xie et al. | Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development | |
| Hertel et al. | Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles |